|
1
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Siegel R, Ward E, Murray T, Xu J
and Thun MJ: Cancer statistics, 2007. CA Cancer J Clin. 57:43–66.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang CC and Li J: An update on
chemotherapy of colorectal liver metastases. World J Gastroenterol.
18:25–33. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Meissner HI, Breen N, Klabunde CN and
Vernon SW: Patterns of colorectal cancer screening uptake among men
and women in the United States. Cancer Epidemiol Biomarkers Prev.
15:389–394. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mansouri D, McMillan DC, Crighton EM and
Horgan PG: Screening for colorectal cancer: What is the impact on
the determinants of outcome? Crit Rev Oncol Hematol. 85:342–349.
2013. View Article : Google Scholar
|
|
6
|
Millar NS and Harkness PC: Assembly and
trafficking of nicotinic acetylcholine receptors (Review). Mol
Membr Biol. 25:279–292. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Schuller HM: Is cancer triggered by
altered signalling of nicotinic acetylcholine receptors? Nat Rev
Cancer. 9:195–205. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Papke RL, Bagdas D, Kulkarni AR, Gould T,
AlSharari SD, Thakur GA and Damaj MI: The analgesic-like properties
of the alpha7 nAChR silent agonist NS6740 is associated with
non-conducting conformations of the receptor. Neuropharmacology.
91:34–42. 2015. View Article : Google Scholar
|
|
9
|
Arias HR, Richards VE, Ng D, Ghafoori ME,
Le V and Mousa SA: Role of non-neuronal nicotinic acetylcholine
receptors in angiogenesis. Int J Biochem Cell Biol. 41:1441–1451.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Russo P and Taly A: α7-Nicotinic
acetylcholine receptors: An old actor for new different roles. Curr
Drug Targets. 13:574–578. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Egleton RD, Brown KC and Dasgupta P:
Nicotinic acetylcholine receptors in cancer: Multiple roles in
proliferation and inhibition of apoptosis. Trends Pharmacol Sci.
29:151–158. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Davis R, Rizwani W, Banerjee S, Kovacs M,
Haura E, Coppola D and Chellappan S: Nicotine promotes tumor growth
and metastasis in mouse models of lung cancer. PLoS One.
4:e75242009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shin VY, Jin HC, Ng EK, Yu J, Leung WK,
Cho CH and Sung JJ: Nicotine and
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induce
cyclooxygenase-2 activity in human gastric cancer cells:
Involvement of nicotinic acetylcholine receptor (nAChR) and
beta-adrenergic receptor signaling pathways. Toxicol Appl
Pharmacol. 233:254–261. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wei P-L, Chang Y-J, Ho Y-S, Lee CH, Yang
YY, An J and Lin SY: Tobacco-specific carcinogen enhances colon
cancer cell migration through α7-nicotinic acetylcholine receptor.
Ann Surg. 49:978–985. 2009. View Article : Google Scholar
|
|
15
|
Di Paolo G and Kim T-W: Linking lipids to
Alzheimer's disease: Cholesterol and beyond. Nat Rev Neurosci.
12:284–296. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pettersson A, Nylund G, Khorram-Manesh A,
Nordgren S and Delbro DS: Nicotine induced modulation of SLURP-1
expression in human colon cancer cells. Auton Neurosci. 148:97–100.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wong HP, Yu L, Lam EK, Tai EK, Wu WK and
Cho CH: Nicotine promotes cell proliferation via alpha7-nicotinic
acetylcholine receptor and catecholamine-synthesizing
enzymes-mediated pathway in human colon adenocarcinoma HT-29 cells.
Toxicol Appl Pharmacol. 221:261–267. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cucina A, Dinicola S, Coluccia P, Proietti
S, D'Anselmi F, Pasqualato A and Bizzarri M: Nicotine stimulates
proliferation and inhibits apoptosis in colon cancer cell lines
through activation of survival pathways. J Surg Res. 178:233–241.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lemos C, Sack U, Schmid F, Juneja M and
Stein U: Anti-metastatic treatment in colorectal cancer: Targeting
signaling pathways. Curr Pharm Des. 19:841–863. 2013. View Article : Google Scholar
|
|
20
|
Chen J, Elfiky A, Han M, Chen C and Saif
MW: The role of Src in colon cancer and its therapeutic
implications. Clin Colorectal Cancer. 13:5–13. 2014. View Article : Google Scholar
|
|
21
|
Grando SA: Connections of nicotine to
cancer. Nat Rev Cancer. 14:419–429. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shi D, Guo W, Chen W, Fu L, Wang J, Tian
Y, Xiao X, Kang T, Huang W and Deng W: Nicotine promotes
proliferation of human nasopharyngeal carcinoma cells by regulating
α7AChR, ERK, HIF-1α and VEGF/PEDF signaling. PLoS One.
7:e438982012. View Article : Google Scholar
|
|
23
|
Dasgupta P, Rastogi S, Pillai S,
Ordonez-Ercan D, Morris M, Haura E and Chellappan S: Nicotine
induces cell proliferation by β-arrestin-mediated activation of Src
and Rb-Raf-1 pathways. J Clin Invest. 116:2208–2217. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dasgupta P, Rizwani W, Pillai S, Davis R,
Banerjee S, Hug K, Lloyd M, Coppola D, Haura E and Chellappan SP:
ARRB1- mediated regulation of E2F target genes in nicotine-induced
growth of lung tumors. J Natl Cancer Inst. 103:317–333. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lin W, Hirata N, Sekino Y and Kanda Y:
Role of α7-nicotinic acetylcholine receptor in normal and cancer
stem cells. Curr Drug Targets. 13:656–665. 2012.PubMed/NCBI
|
|
26
|
Wei PL, Kuo LJ, Huang MT, Ting WC, Ho YS,
Wang W, An J and Chang YJ: Nicotine enhances colon cancer cell
migration by induction of fibronectin. Ann Surg Oncol.
18:1782–1790. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Guo J, Ibaragi S, Zhu T, Luo LY, Hu GF,
Huppi PS and Chen CY: Nicotine promotes mammary tumor migration via
a signaling cascade involving protein kinase C and CDC42. Cancer
Res. 68:8473–8481. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chipitsyna G, Gong Q, Anandanadesan R,
Alnajar A, Batra SK, Wittel UA, Cullen DM, Akhter MP, Denhardt DT,
Yeo CJ, et al: Induction of osteopontin expression by nicotine and
cigarette smoke in the pancreas and pancreatic ductal
adenocarcinoma cells. Int J Cancer. 125:276–285. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sullivan J, Blair L, Alnajar A, Aziz T, Ng
CY, Chipitsyna G, Gong Q, Witkiewicz A, Weber GF, Denhardt DT, et
al: Expression of a prometastatic splice variant of osteopontin,
OPNC, in human pancreatic ductal adenocarcinoma. Surgery.
146:232–240. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Khalil AA, Jameson MJ, Broaddus WC, Lin PS
and Chung TD: Nicotine enhances proliferation, migration, and
radioresistance of human malignant glioma cells through EGFR
activation. Brain Tumor Pathol. 30:73–83. 2013. View Article : Google Scholar
|
|
31
|
Vukelic M, Qing X, Redecha P, Koo G and
Salmon JE: Cholinergic receptors modulate immune complex-induced
inflammation in vitro and in vivo. J Immunol. 191:1800–1807. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Song P, Sekhon HS, Jia Y, Keller JA,
Blusztajn JK, Mark GP and Spindel ER: Acetylcholine is synthesized
by and acts as an autocrine growth factor for small cell lung
carcinoma. Cancer Res. 63:214–221. 2003.PubMed/NCBI
|
|
33
|
Song P, Sekhon HS, Lu A, Arredondo J,
Sauer D, Gravett C, Mark GP, Grando SA and Spindel ER: M3
muscarinic receptor antagonists inhibit small cell lung carcinoma
growth and mitogen-activated protein kinase phosphorylation induced
by acetylcholine secretion. Cancer Res. 67:3936–3944. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Song P, Sekhon HS, Fu XW, Maier M, Jia Y,
Duan J, Proskosil BJ, Gravett C, Lindstrom J, Mark GP, et al:
Activated cholinergic signaling provides a target in squamous cell
lung carcinoma. Cancer Res. 68:4693–4700. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Osaki M, Oshimura M and Ito H: PI3K-Akt
pathway: Its functions and alterations in human cancer. Apoptosis.
9:667–676. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sheng S, Qiao M and Pardee AB: Metastasis
and AKT activation. J Cell Physiol. 218:451–454. 2009. View Article : Google Scholar
|
|
37
|
Kim D, Kim S, Koh H, Yoon SO, Chung AS,
Cho KS and Chung J: Akt/PKB promotes cancer cell invasion via
increased motility and metalloproteinase production. FASEB J.
15:1953–1962. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang G, Wang F, Ding W, Wang J, Jing R, Li
H, Wang X, Wang Y, Ju S and Wang H: APRIL induces tumorigenesis and
metastasis of colorectal cancer cells via activation of the
PI3K/Akt pathway. PLoS One. 8:e552982013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Li Q, Li M, Wang YL, Fauzee NJ, Yang Y,
Pan J, Yang L and Lazar A: RNA interference of PARG could inhibit
the metastatic potency of colon carcinoma cells via PI3-kinase/Akt
pathway. Cell Physiol Biochem. 29:361–372. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Weiland S, Bertrand D and Leonard S:
Neuronal nicotinic acetylcholine receptors: From the gene to the
disease. Behav Brain Res. 113:43–56. 2000. View Article : Google Scholar : PubMed/NCBI
|
